- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05725395
Virtual Reality as a Intrinsic Motivation Intervention
Virtual Reality Education for Hospitalized Pediatric Patients Improves Intrinsic Motivation: A Prospective Crossover Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
While virtual reality has gained momentum as a therapeutic supplement to distract from pain perception and to reduce anxiety, it has received less attention as an intervention to promote more holistic psychological intrinsic motivation in the course of in-patient care. Child and adolescent self-reported measures of intrinsic motivation have also been looked over in favor of parent or practitioner measures of a child's intrinsic motivation.
To evaluate the effectiveness of virtual reality on child and adolescent intrinsic motivation while undergoing hospital care, the investigators will determine the effect of virtual reality to 1) increase pediatric patient intrinsic motivation compared to standard of care using educational virtual reality, 2) establish a comprehensive profile of short-term psychological well-being in school-aged children and adolescents following admission to a hospital. Participants will serve as their own control to either receive intervention on the first day or second day of the in-patient care and no intervention will be given on the other day.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Palo Alto, California, United States, 94304
- Lucile Packard Children's Hospital Stanford
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients' age range from 5 to 25 at LPCH/SHC facilities
- patient who speak english only
Exclusion Criteria:
- Participants who do not consent
- Have a history of seizure disorder
- Currently have nausea
- Have motion sickness
- Are clinically unstable
- Currently using corrective glasses (not compatible with VR headset)
- Currently pregnant
- non-English speakers
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Virtual Reality then Standard of Care
Participants will be randomized to receive the virtual reality intervention on the first day and receive standard of care on the second day of in-patient care.
|
During in-patient care participants will be randomized to receive or not receive the educational virtual reality intervention on the first day.
After two days, participants will receive a total of 10 minutes interventional in the morning (between 8am to 12pm) every day until their in-patient care concludes.
For case control, participants will service as their self control and be randomized to receive no virtual reality intervention on either the first day or the second day of in-patient care.
|
|
Experimental: Standard of Care then Virtual Reality
Participants will be randomized to receive the standard of care on the first day and receive virtual reality intervention on the second day of in-patient care.
|
During in-patient care participants will be randomized to receive or not receive the educational virtual reality intervention on the first day.
After two days, participants will receive a total of 10 minutes interventional in the morning (between 8am to 12pm) every day until their in-patient care concludes.
For case control, participants will service as their self control and be randomized to receive no virtual reality intervention on either the first day or the second day of in-patient care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in the intrinsic motivation
Time Frame: Day 1(baseline), Day 2
|
Measured with six items from the modified Intrinsic Motivation Inventory (IMI) - Interest/Enjoyment Subscale.
The perceived interest/enjoyment is scored on scale ranging from 1 (Not at all true) to 7 (very true)
|
Day 1(baseline), Day 2
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in educational self efficacy
Time Frame: Day 1(baseline), Day 2
|
Measured with six items from the modified New General Self-Efficacy Scale.
The educational self efficacy is scored on scale ranging from 1 (strongly disagree) to 5 (strongly agree)
|
Day 1(baseline), Day 2
|
|
Change in current mental well being as measured by the modified WHO (Five) Well-Being Index
Time Frame: Day 1(baseline), Day 2
|
The modified WHO (Five) Well-Being Index is a participant-reported outcome measure that assesses current mental well being.
Questionnaire contains 5 questions .
Scores range from 0 to 5, with higher scores indicating the corresponding feeling exists all the time.
|
Day 1(baseline), Day 2
|
|
Change in the self-esteem (child)
Time Frame: Day 1(baseline), Day 2
|
Measured with five items from the modified Rosenberg Self-Esteem Scale (child).
The self-esteem is scored on scale ranging from 1 (very true) to 4 (Definitely not true)
|
Day 1(baseline), Day 2
|
|
Change in the self-esteem (Adolescent)
Time Frame: Day 1(baseline), Day 2
|
Measured with five items from the modified Rosenberg Self-Esteem Scale (Adolescent).
The self-esteem is scored on scale ranging from 1 (Strongly agree) to 4 (Strongly disagree)
|
Day 1(baseline), Day 2
|
|
Change in the caregiver perception of the educational experience of the patient
Time Frame: Day 1(baseline), Day 2
|
Measured with seven items from a modified Educational Experience Parental Survey Scale.
The caregiver perception of the educational experience of the patient is scored on scale ranging from 1 (strongly disagree) to 7 (strongly agree)
|
Day 1(baseline), Day 2
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in the Positive and Negative Affect feeling and emotion for Children
Time Frame: Day 1(baseline), Day 2
|
Measured with ten items from the Positive and Negative Affect Schedule for Children (PANAS-C).
The positive affect (PA) and negative affect (NA) feelings and emotions are scored on scale ranging from 1 (Very slightly or not at all) to 5 (Extremely)
|
Day 1(baseline), Day 2
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Diener E, Emmons RA, Larsen RJ, Griffin S. The Satisfaction With Life Scale. J Pers Assess. 1985 Feb;49(1):71-5. doi: 10.1207/s15327752jpa4901_13.
- Smith BW, Dalen J, Wiggins K, Tooley E, Christopher P, Bernard J. The brief resilience scale: assessing the ability to bounce back. Int J Behav Med. 2008;15(3):194-200. doi: 10.1080/10705500802222972.
- Duckworth AL, Peterson C, Matthews MD, Kelly DR. Grit: perseverance and passion for long-term goals. J Pers Soc Psychol. 2007 Jun;92(6):1087-101. doi: 10.1037/0022-3514.92.6.1087.
- Duckworth AL, Quinn PD. Development and validation of the short grit scale (grit-s). J Pers Assess. 2009 Mar;91(2):166-74. doi: 10.1080/00223890802634290.
- Kallem S, Carroll-Scott A, Rosenthal L, Chen E, Peters SM, McCaslin C, Ickovics JR. Shift-and-persist: a protective factor for elevated BMI among low-socioeconomic-status children. Obesity (Silver Spring). 2013 Sep;21(9):1759-63. doi: 10.1002/oby.20195. Epub 2013 May 13.
- Lachman ME, Weaver SL. The sense of control as a moderator of social class differences in health and well-being. J Pers Soc Psychol. 1998 Mar;74(3):763-73. doi: 10.1037//0022-3514.74.3.763.
- Kern ML, Benson L, Steinberg EA, Steinberg L. The EPOCH Measure of Adolescent Well-Being. Psychol Assess. 2016 May;28(5):586-97. doi: 10.1037/pas0000201. Epub 2015 Aug 24.
- Rosenberg M. [Consciousness from the viewpoint of electrophysics]. Psychiatr Neurol Med Psychol (Leipz). 1965 Nov;17(11):408-10. No abstract available. German.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 68166
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.